Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
JCR Impact Factor (IF) – 2.1 (5-Year IF – 2.0)
Journal Citation Indicator (JCI) (2023) – 0.4
Scopus CiteScore – 3.7 (CiteScore Tracker 3.8)
Index Copernicus  – 171.00; MNiSW – 70 pts

ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2015, vol. 24, nr 2, March-April, p. 245–250

doi: 10.17219/acem/41375

Publication type: original article

Language: English

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Serum Vitamin D and the Metabolic Syndrome Among Osteoporotic Postmenopausal Female Patients of a Family Practice Clinic in Jordan

Nada Yasein1,A,B,C,E,F, Wejdan Shroukh2,A,B,C,D,E, Razan Hijjawi3,A,B,C,D

1 Department of Family and Community Medicine, Faculty of Medicine, University of Jordan, Amman, Jordan

2 Department of Pharmacy, University of Jordan, Amman, Jordan

3 Department of Family and Community Medicine, Faculty of Medicine, Jordan University Hospital, Amman, Jordan

Abstract

Background. Vitamin D deficiency and insufficiency and the metabolic syndrome are two common health issues worldwide. The association between these two health problems is subject to debate.
Objectives. This study aims to investigate the association between vitamin D deficiency or insufficiency and the metabolic syndrome in a sample of osteoporotic postmenopausal women attending a family practice clinic in Amman – Jordan.
Material and Methods. This was an observational cross sectional study. It was carried out in the family practice clinic in Jordan University Hospital. The study included all postmenopausal osteoporotic women attending the clinic between June 2011 and May 2012, yielding a total of 326 subjects. The association between metabolic syndrome and serum vitamin D levels was investigated.
Results. Waist circumference, body mass index, triglycerides and fasting blood sugar were significantly higher among postmenopausal women with metabolic syndrome, but HDL cholesterol was significantly lower (p < 0.05). The prevalence of metabolic syndrome among all study participants was 42.9%. Triglycerides and LDL cholesterol were significantly higher among women deficiency or insufficiency (p < 0.05). The prevalence of vitamin D deficiency or insufficiency was 45.7%. Among patients with metabolic syndrome, the prevalence of vitamin D deficiency or insufficiency was 50.7%.
Conclusion. Findings of the current study suggest a lack of relationship between serum vitamin D and metabolic syndrome. However, a significant inverse relationship was found between serum vitamin D levels and both serum triglycerides and LDL levels.

Key words

metabolic syndrome, osteoporotic, postmenopausal.

References (30)

  1. Lee JH, O’Keefe JH, Bell D, Hensrud DD, Holick MF: Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol 2008, 9, 52, 1949–1956.
  2. Marjani A, Moghasemi S: Serum vitamin D and metabolic syndrome among postmenopausal women in Gorgan. Biomed Res 2012, 23, 275–280.
  3. Marjani A, Moghasemi S: The Metabolic Syndrome among Postmenopausal Women in Gorgan. Int J Endocrinol 2012, 2012, 953627.
  4. Chedraui P, Hidalgo L, Chavez D, Morocho N, Alvarado M, Huc A: Quality of life among postmenopausal Ecuadorian women participating in a metabolic syndrome screening program. Maturitas 2007, 20, 56, 45–53.
  5. Ding QF, Hayashi T, Zhang XJ, Funami J, Ge L, Li J: Risks of CHD identified by different criteria of metabolic syndrome and related changes of adipocytokines in elderly postmenopausal women. J Diabetes Complications 2007, 21, 315–319.
  6. Reis JP, von Muhlen D, Miller ER: Relation of 25-hydroxyvitamin D and parathyroid hormone levels with metabolic syndrome among US adults. Eur J Endocrinol 2008, 159, 41–48.
  7. Anderson JL, May HT, Horne BD, Bair TL, Hall NL, Carlquist JF: Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am J Cardiol 2010, 106, 963–968.
  8. Adams JS, Hewison M: Update in vitamin D. J Clin Endocrinol Metab 2010, 95, 471–478.
  9. McGill AT, Stewart JM, Lithander FE, Strik CM, Poppitt SD: Relationships of low serum vitamin D3 with anthropometry and markers of the metabolic syndrome and diabetes in overweight and obesity. Nutr J 2008, 7, 4.
  10. Scragg R, Sowers M, Bell C: Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 2004, 27, 2813–2818.
  11. Karhapaa P, Pihlajamaki J, Porsti I, Kastarinen M, Mustonen J, Niemela O: Diverse associations of 25-hydroxyvitamin D and 1,25-dihydroxy-vitamin D with dyslipidaemias. J Intern Med 2010, 268, 604–610.
  12. Martins D, Wolf M, Pan D, Zadshir A, Tareen N, Thadhani R: Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 2007, 167, 1159–1165.
  13. Utian WH: Ovarian function, therapy-oriented definition of menopause and climacteric. Exp Gerontol 1994, 29, 245–251.
  14. Premaor MO, Compston JE: Testing for secondary causes of osteoporosis. BMJ 2010, 341, c6959.
  15. Prevention and management of osteoporosis. World Health Organ Tech Rep Ser 2003, 921, 1–164, back cover.
  16. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002, 106, 3143–3421.
  17. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000, 894, i–xii, 1–253.
  18. Jeon YK, Lee JG, Kim SS, Kim BH, Kim SJ, Kim YK: Association between bone mineral density and metabolic syndrome in preand postmenopausal women. Endocr J 2011, 58, 87–93.
  19. Tanko LB, Christiansen C, Cox DA, Geiger MJ, McNabb MA, Cummings SR: Relationship between osteoporosis and cardiovascular disease in postmenopausal women. J Bone Miner Res 2005, 20, 1912–1920.
  20. Hwang DK, Choi HJ: The relationship between low bone mass and metabolic syndrome in Korean women. Osteoporos Int 2010, 21, 425–431.
  21. Yasein NA, Irshaid YM, Barghouti FF, Shroukh WA, Halaseh LJ: Use of Antihypertensive Medications among Elderly Patients with Metabolic Syndrome Attending Family Practice Clinic. International Medical Journal 2013, 20, 132–135.
  22. Isordia-Salas I, Santiago-German D, Rodriguez-Navarro H, Almaraz-Delgado M, Leanos-Miranda A, Anaya-Gomez F: Prevalence of metabolic syndrome components in an urban Mexican sample: comparison between two classifications. Exp Diabetes Res 2012, 2012, 202540.
  23. Lips P, Hosking D, Lippuner K, Norquist JM, Wehren L, Maalouf G: The prevalence of vitamin D inadequacy amongst women with osteoporosis: an international epidemiological investigation. J Intern Med 2006, 260, 245–254.
  24. Holick MF, Siris ES, Binkley N, Beard MK, Khan A, Katzer JT: Prevalence of Vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab 2005, 90, 3215–3224.
  25. Bruyere O, Malaise O, Neuprez A, Collette J, Reginster JY: Prevalence of vitamin D inadequacy in European postmenopausal women. Curr Med Res Opin 2007, 23, 1939–1944.
  26. Vacek JL, Vanga SR, Good M, Lai SM, Lakkireddy D, Howard PA: Vitamin D deficiency and supplementation and relation to cardiovascular health. Am J Cardiol 2012, 109, 359–363.
  27. Yin X, Sun Q, Zhang X, Lu Y, Sun C, Cui Y: Serum 25(OH)D is inversely associated with metabolic syndrome risk profile among urban middle-aged Chinese population. Nutrition Journal 2012, 11, 1–7.
  28. Jorde R, Grimnes G: Vitamin D and metabolic health with special reference to the effect of vitamin D on serum lipids. Prog Lipid Res 2011, 50, 303–312.
  29. Blumberg JM, Tzameli I, Astapova I, Lam FS, Flier JS, Hollenberg AN: Complex role of the vitamin D receptor and its ligand in adipogenesis in 3T3-L1 cells. J Biol Chem 2006, 281, 11205–11213.
  30. Kong J, Li YC: Molecular mechanism of 1,25-dihydroxyvitamin D3 inhibition of adipogenesis in 3T3-L1 cells. Am J Physiol Endocrinol Metab 2006, 290, 916–924.
© Wroclaw Medical University